Stable Chemiluminescence Immunoassay Analyzer Supplier -ZECEN

ZECEN BIO

Zecen Biotech CO., LTD. founded in 2011, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

CLIA、POCLIA、Biochemistry

ZECEN Focused on IVD Innovation

A GLOBAL BRAND CDMO SERVICE

Chemiluminescence immunoassay analyzer manufacturers

ZECEN BIO

Zecen Biotech CO., LTD. founded in 2011, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

ZECEN — CLIA Manufacturer & Supplier

One-Stop CDMO, OEM & ODM Partner for IVD Diagnostics
Chemiluminescence Immunoassay Systems & Reagents Customization

Get A Free Quote

ZECEN DIAGNOSTICS DEVICES AND REAGENTS

ZECEN is best known for its research and development of unique markers across a wide range of disorders including thyroid, cancer, hormones，infectious diseases, and cardiac.

CIA 1200M

Chemiluminescence Immunoassay 120T/H Clinical Diagnostic Analyzer

Poclia Plus

Double Chamber 16 channerls

POCT CLIA Analyzer

Poclia Miuns

Single Serving-8 channles

POCT CLIA Analyzer

CIA 1800

Chemiluminescence Immunoassay 220T/H Clinical Diagnostic Analyzer

ABOUT ZECEN

Zecen Biotech Co., Ltd. was founded in 2011 and is an in vitro diagnostic (IVD) enterprise focused on fully automated chemiluminescence immunoassay (CLIA) total solutions as its core offering. The company specializes in the R&D, manufacturing, and sales of IVD reagents and instruments, with R&D and production bases established in Beijing, Wuxi, Weifang, and Taizhou. Its Taizhou production center, located in China Medical City, houses an 8,000 m² GMP‑compliant facility.

Deeply committed to the field of chemiluminescence immunoassay (CLIA), Zecen Biotech Co., Ltd. has built a complete IVD industrial chain encompassing core raw material R&D, reagent production, and fully automated instrument manufacturing. It is one of the few companies in China’s CLIA sector with full‑chain independent intellectual property rights. The company's proprietary fully automated tube‑based magnetic particle chemiluminescence immunoassay analytical system, which combines magnetic particle separation with chemiluminescent enzyme immunoassay, extends the linear range of detection and significantly improves both detection sensitivity and analytical throughput. In the preparation of magnetic particles and luminescent substrates, the company has applied for multiple invention patents and has mastered comprehensive, leading‑edge technologies in core steps such as magnetic bead conjugation, antibody labeling, and substrate synthesis.

Full‑chain self‑sufficiency and control

95% of core raw materials are self‑supplied.
Holds complete intellectual property rights for the tube‑based magnetic particle chemiluminescence immunoassay analytical system.
Multiple invention patents in areas including magnetic microspheres and luminescent substrate preparation.

Extensive product registration certificates

180 Class II registration certificates.
13 Class III registration certificates.
100+ CE‑marked reagent menu items.
Assay menu covers cardiology, hormones, thyroid function, infectious diseases, tumor markers, glucose metabolism, bone metabolism, inflammation, women's & children's health, and other fields.

Scaled production and delivery capacity

8,000 m² GMP‑certified production base.
500 m² diagnostic reagent R&D laboratory.
Annual instrument production capacity: 5,000 units; annual reagent production capacity: 100 million tests.

Global collaboration and outreach

CDMO strategic partnership with Sysmex Corporation, the world's sixth‑largest IVD company.
OEM/ODM collaborations with multiple renowned IVD enterprises both domestically and internationally.
Products sold in 30+ countries worldwide, covering Europe, Southeast Asia, the Middle East, Africa, and Latin America.

Leveraging its strong technological capabilities, Zecen Biotech Co., Ltd. actively expands its CDMO/OEM/ODM service models. The company has entered into a strategic collaboration with Sysmex Corporation, the world's sixth‑largest IVD company, providing custom R&D and manufacturing outsourcing services under a CDMO arrangement. Beyond its proprietary business, Zecen Biotech Co., Ltd. currently partners with numerous well‑known IVD enterprises both domestically and internationally, offering one‑stop solutions for chemiluminescence raw materials, reagent kits, and detection systems.

In the international market, the company's products have successfully entered regions including Europe, Southeast Asia, the Middle East, Africa, and Latin America, with sales in more than 30 countries worldwide. Our core technological barriers not only ensure product stability and cost‑effectiveness but also guarantee a highly stable and controllable supply chain. Choosing Zecen means you receive not just diagnostic instruments, but a fully integrated, worry‑free CLIA solution.

AVAILABLE SERVICE & PARTNERSHIP

Terminal Service

Full‑Lifecycle Services for CLIA Instruments: Pre‑sales Consultation, Installation, Technical Support, and After‑sales Maintenance.

A Global Brand

Zecen Biotech Co., Ltd. provides end‑to‑end service support for fully automated chemiluminescence immunoassay (CLIA) instruments, covering pre‑sales consultation, installation and commissioning, technical support, and after‑sales maintenance throughout the instrument lifecycle.

With R&D and production bases located in Beijing, Weifang (Shandong), and Taizhou (Jiangsu), the company has built a nationwide service network to ensure rapid response to customer needs.

View service support

CDMO Cooperation

CDMO/OEM/ODM Collaboration Services for IVD Core Raw Materials and Reagents.

A Global Brand

Leveraging its complete intellectual property rights for the tube‑based magnetic particle chemiluminescence immunoassay analytical system, Zecen Biotech Co., Ltd. offers full‑chain services for global IVD companies—

from core raw material R&D and customized reagent kit development to detection system integration—backed by an 8,000 m² GMP‑compliant manufacturing facility and a 500 m² diagnostic reagent R&D laboratory.

View CDMO cooperation

FOCUSING ON CLIA FIELD APPLICATIONS

Cooperative Company

AroCell Group consist of AroCell AB and IDL Biotech.

Cooperative Project

Tissue Polypeptide Specific

Antigen (TPS®).

Cooperative Mode

IDL reached a strategic partnership

with ZECEN in 2019.

AVAILABLE OEM,

ODM AND CUSTOMIZED SERVICE

Zecen Biotech has more than 40 engineers. Three international business engineers and two technical support engineers.

Contract Development/

Manufacturing Organization (CDMO)

The first choice in CDMO for IVD materials and expertise ZECEN is best known for

its research and development of unique markers across a wide range of disorders including thyroid, cancer, hormones infectious diseases, and cardiac.

The Complete

Cdmo Package

Our competence to supply IVD raw materials and develop novel biomarkers,

uniquely positions us in the market as the primary content provider to the diagnostics industry.

Critical Raw

Materials Manufacturing

We develop and manufacture core materials and antibodies and

have the capacity to supply them at scale anywhere in the world.

LOOKING FOR HELP

ON IMMUNOASSAY ANALYZER?

Our current products include more than 100 assays, from thyroid, inflammation, diabetes, tumer markers, immune disorders, hormones to cardiac markers. Our ever-expanding test menu helps our customers and collaborators keep up with the demands of healthcare sector. Zecen is striving for innovation and perfection to deliver the best products to the customers.

DIGITAL SHOWROOM

If you want to learn more about our manufacturing capabilities, you can click on the avatar in the scene, or accept my invitation!

INNOVATIVE CLIA FIELD INSIGHTS

Zecen focus on the Chemiluminescent immunoassay (CLIA) field.

Sysmex and Zecen promote comprehensive and in-depth cooperation and explore diversified cooperation modes

Sysmex and Zecen promote comprehensive and in-depth cooperation and explore diversified cooperation modesIn March 2023, Sysmex Medical Electronics (Shanghai) Co., Ltd. and Jiangsu Zecen Biotech Co., Ltd. signed a strategic cooperation agreement to jointly promote the localization of high-sensitivity

2023-10-21

Tissue peptide-specific antigen TPS Product Launch Event with complete success

Tissue peptide-specific antigen TPS Product Launch Event with complete successOn May 27, ZECEN successfully held the TPS new product launch conference at CACLP in Nanchang.Participants included experts from Sweden's IDL biotech, experts from China's in vitro diagnostic industry, professors and partn

2023-10-21

How to Choose a CLIA Analyzer by Throughput and Lab Size

Choose the perfect CLIA analyzer for your lab. Learn to calculate peak throughput, evaluate real-world capacity, and optimize your workflows.

2026-08-08

POCT CLIA Analyzer Applications in Emergency and Primary Care Testing

Learn how POCT CLIA analyzers reduce diagnostic TAT, improve outcomes, and optimize hospital workflows with rapid, accurate bedside testing.

2026-07-16

ZECEN DIAGNOSTICS DEVICES AND REAGENTS

ABOUT ZECEN

Full‑chain self‑sufficiency and control

Extensive product registration certificates

Scaled production and delivery capacity

Global collaboration and outreach

AVAILABLE SERVICE & PARTNERSHIP

Terminal Service

A Global Brand

CDMO Cooperation

A Global Brand

FOCUSING ON CLIA FIELD APPLICATIONS

Cooperative Company

Cooperative Project

Cooperative Mode

AVAILABLE OEM,

ODM AND CUSTOMIZED SERVICE

Contract Development/

Manufacturing Organization (CDMO)

The Complete

Cdmo Package

Critical Raw

Materials Manufacturing

LOOKING FOR HELP

ON IMMUNOASSAY ANALYZER?

INNOVATIVE CLIA FIELD INSIGHTS

Sysmex and Zecen promote comprehensive and in-depth cooperation and explore diversified cooperation modes

Tissue peptide-specific antigen TPS Product Launch Event with complete success

How to Choose a CLIA Analyzer by Throughput and Lab Size

POCT CLIA Analyzer Applications in Emergency and Primary Care Testing

QUICK LINKS

PRODUCTS CATEGORY

CONTACT US